Clinical trial

A Study in Type 1 Diabetic Patients With Repeated Doses of E1 in Combination With G1

NCT00239148

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-06-01

PhasePHASE1

Study timeline

Study start (unknown)2005-06-01Date precision: month

Registry last updated2019-10-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 1 Diabetesunresolved

Interventions

E1 and G1DRUG

Sponsors & collaborators

OPKO Health, Inc.lead sponsor

Mapped research locations

San AntonioTexas, United States1 DurhamNorth Carolina, United States1 BuffaloNew York, United States1 Walnut CreekCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00239148 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.